| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Kmell J, Vizi ES, Knoll B |
Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD |
Acta Physiol. Acad. ... |
1970 |
| Knoll J, Vizi ES |
Cross-tolerance between para-bromo-methamphetamine (V-111) and LSD-5 |
Pharmacology |
1970 |
| Gaston TR, Rasmussen GT |
Identification of 3,4 methylenedioxymethamphetamine |
Bureau of Narcotics ... |
1972 |
| Seiden LS, Fischman MW, S... |
Long-term methamphetamine induced changes in brain catecholamines in t... |
Drug Alcohol Depend |
1976 |
| Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
| Gehlert DR, Schmidt CJ, W... |
Evidence for specific methylenedioxymethamphetamine (ecstasy) binding ... |
Eur J Pharmacol |
1985 |
| Seymour RB, Wesson DR, Sm... |
MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conferenc... |
J Psychoactive Drugs |
1986 |
| Beardsley PM, Balster RL,... |
Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus ... |
Drug Alcohol Depend |
1986 |
| Brady JF, Di Stefano EW, ... |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphet... |
Life Sci |
1986 |
| Evans SM, Johanson CE |
Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamph... |
Drug Alcohol Depend |
1986 |
| Kamien JB, Johanson CE, S... |
The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylene... |
Drug Alcohol Depend |
1986 |
| Lyon RA, Glennon RA, Tite... |
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... |
Psychopharmacology (... |
1986 |
| Schmidt CJ, Wu L, Lovenbe... |
Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine an... |
Eur J Pharmacol |
1986 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Evans SM, Johanson CE |
Discriminative stimulus properties of ±-3,4-methylenedioxymethamphetam... |
Drug Alcohol Depend |
1986 |
| Battaglia G, Yeh SY, O'He... |
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... |
J Pharmacol Exp Ther |
1987 |
| Frith CH, Chang LW, Latti... |
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... |
Fundam Appl Toxicol |
1987 |
| Kulmala HK, Boja JW, Sche... |
Behavioral suppression following 3,4-methylenenedioxymethamphetamine |
Life Sci |
1987 |
| Lamb RJ, Griffiths RR |
Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the ... |
Psychopharmacology (... |
1987 |
| Mokler DJ, Robinson SE, R... |
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... |
Eur J Pharmacol |
1987 |
| Peroutka SJ |
Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine... |
N Engl J Med |
1987 |
| Peroutka SJ, Pascoe N, Fa... |
Monoamine metabolites in the cerebralspinal fluid of recreational user... |
Research Comm in Sub... |
1987 |
| Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
| Steele TD, Nichols DE, Yi... |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... |
Biochem Pharmacol |
1987 |
| Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
| Stone DM, Merchant KM, Ha... |
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... |
Neuropharmacology |
1987 |
| Wang SS, Ricaurte GA, Per... |
[3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain m... |
Eur J Pharmacol |
1987 |
| Battaglia G, Brooks BP, K... |
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... |
Eur J Pharmacol |
1988 |
| Bost RO |
3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivat... |
J Forensic Sci |
1988 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
| Johnson M, Letter AA, Mer... |
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... |
J Pharmacol Exp Ther |
1988 |
| Lim HK, Foltz RL |
In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine... |
Chem Res Toxicol |
1988 |
| Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
| Nencini P, Woolverton WL,... |
Enhancement of morphine-induced analgesia after repeated injections of... |
Brain Res |
1988 |
| O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
| Peroutka SJ, Newman H, Ha... |
Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... |
Neuropsychopharmacol... |
1988 |
| Ramos JM Jr, Fitzgerald R... |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/met... |
Clin Chem |
1988 |
| Ricaurte GA, DeLanney LE,... |
5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergi... |
Brain Res |
1988 |
| Ricaurte GA, Forno LS, Wi... |
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... |
JAMA |
1988 |
| Ruangyuttikarn W, Moody D... |
Comparison of three commercial amphetamine immunoassays for detection ... |
J Anal Toxicol |
1988 |
| Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
| Schmidt CJ, Taylor VL |
Direct central effects of acute methylenedioxymethamphetamine on serot... |
Eur J Pharmacol |
1988 |
| Slikker W Jr, Ali SF, Sca... |
Neurochemical and neurohistological alterations in the rat and monkey ... |
Toxicol Appl Pharmac... |
1988 |
| Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
| Yamamoto BK, Spanos LJ |
The acute effects of methylenedioxymethamphetamine on dopamine release... |
Eur J Pharmacol |
1988 |
| Price LH, Ricaurte GA, Kr... |
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... |
Arch Gen Psychiatry |
1989 |
| Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
| Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
| Crisp T, Stafinsky JL, Bo... |
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA... |
Pharmacol Biochem Be... |
1989 |
| Fitzgerald RL, Blanke RV,... |
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... |
J Chromatogr |
1989 |
| Gazzara RA, Takeda H, Cho... |
Inhibition of dopamine release by methylenedioxymethamphetamine is med... |
Eur J Pharmacol |
1989 |
| Hekmatpanah CR, McKenna D... |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... |
Neurosci Lett |
1989 |
| Hiramatsu M, Nabeshima T,... |
The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1989 |
| Insel TR, Battaglia G, Jo... |
3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... |
J Pharmacol Exp Ther |
1989 |
| Johnson M, Hanson GR, Gib... |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... |
Eur J Pharmacol |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Kelland MD, Freeman AS, C... |
(+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal a... |
Eur J Pharmacol |
1989 |
| Lim HK, Foltz RL |
Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... |
Chem Res Toxicol |
1989 |
| Lowy MT, Nash JF Jr, Melt... |
Selective reduction of striatal type II glucocorticoid receptors in ra... |
Eur J Pharmacol |
1989 |
| Matthews RT, Champney TH,... |
Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopam... |
Pharmacol Biochem Be... |
1989 |
| Nader MA, Hoffmann SM, Ba... |
Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... |
Psychopharmacology (... |
1989 |
| Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
| Seiden LS, Kleven MS |
Methamphetamine and related drugs: toxicity and resulting behavioral c... |
NIDA Res Monogr |
1989 |
| Spanos LJ, Yamamoto BK |
Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MD... |
Pharmacol Biochem Be... |
1989 |
| Sprouse JS, Bradberry CW,... |
MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal... |
Eur J Pharmacol |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Wilson MA, Ricaurte GA, M... |
Distinct morphologic classes of serotonergic axons in primates exhibit... |
Neuroscience |
1989 |
| Zaczek R, Hurt S, Culp S,... |
Characterization of brain interactions with methylenedioxyamphetamine ... |
NIDA Res Monogr |
1989 |
| Bilsky EJ, Hui YZ, Hubbel... |
Methylenedioxymethamphetamine's capacity to establish place preference... |
Pharmacol Biochem Be... |
1990 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| Cho AK, Hiramatsu M, Dist... |
Stereochemical differences in the metabolism of 3,4-methylenedioxymeth... |
Drug Metab Dispos |
1990 |
| Cody JT |
Detection of D,L-amphetamine, D,L-methamphetamine, and illicit ampheta... |
J Anal Toxicol |
1990 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| Fitzgerald JL, Reid JJ |
Effects of methylenedioxymethamphetamine on the release of monoamines ... |
Eur J Pharmacol |
1990 |
| Fitzgerald RL, Blanke RV,... |
Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine ... |
Chirality |
1990 |
| Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
| Hashimoto K, Goromaru T |
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... |
Neuropharmacology |
1990 |
| Hashimoto K, Goromaru T |
Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake ... |
Fundam Clin Pharmaco... |
1990 |
| Hekmatpanah CR, Peroutka ... |
5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... |
Eur J Pharmacol |
1990 |
| Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
| Hiramatsu M, Kumagai Y, U... |
Metabolism of methylenedioxymethamphetamine: formation of dihydroxymet... |
J Pharmacol Exp Ther |
1990 |
| Kunsman GW, Manno JE, Coc... |
Application of the Syva EMIT and Abbott TDx amphetamine immunoassays t... |
J Anal Toxicol |
1990 |
| McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
| Nash JF, Meltzer HY, Gude... |
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... |
J Neurochem |
1990 |
| Oberlender R, Nichols DE |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... |
J Pharmacol Exp Ther |
1990 |
| Poland RE |
Diminished corticotropin and enhanced prolactin responses to 8-hydroxy... |
Neuropharmacology |
1990 |
| Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
| Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
| Schmidt CJ, Black CK, Abb... |
Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Black CK, Abb... |
Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity a... |
Brain Res |
1990 |
| Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Taylor VL |
Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by ... |
Eur J Pharmacol |
1990 |
| Sprouse JS, Bradberry CW,... |
3,4-Methylenedioxymethamphetamine-induced release of serotonin and inh... |
Eur J Pharmacol |
1990 |
| Winslow JT, Insel TR |
Serotonergic modulation of rat pup ultrasonic vocal development: studi... |
J Pharmacol Exp Ther |
1990 |
| Yousif MY, Fitzgerald RL,... |
Identification of metabolites of 3,4-methylenedioxymethamphetamine in ... |
Drug Alcohol Depend |
1990 |
| Zacny JP, Virus RM, Woolv... |
Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1990 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Nash JF, Arora RC, Schrei... |
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... |
Biochem Pharmacol |
1991 |
| Nash JF, Brodkin J |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dop... |
J Pharmacol Exp Ther |
1991 |
